Clinical Trial Update: A(f)MAZE-CABG Study [NA]

View source ↗

Summary

Abbott Medical Devices' A(f)MAZE-CABG trial has been terminated; the study investigated treatment for coronary artery disease and atrial fibrillation in the set…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Arteriosclerosis, Atrial Fibrillation | NA | Status: TERMINATED